New research aims to make prostate cancer prognostics more precise
A team of RI-MUHC researchers is developing DNA biomarkers to better pinpoint treatment options for patients with prostate cancer
Leading the way towards improved treatment for atrial fibrillation
Always on the lookout for major developments in electrophysiology, MUHC clinical teams work closely with research teams at the RI-MUHC to offer the most innovative treatments to patients
New advances in lung cancer treatment
Results of an international clinical trial confirm the efficiency of an immunotherapy treatment for early stage non-small cell lung cancer
A new research study may reduce surgical interventions for baby girls
Work by a team of child health researchers from the RI-MUHC and across Canada provides new insights into treatment for fetal ovarian cysts
How do we define death? Canada now has clear clinical guidelines
Brain-based definition of death becomes the central concept of the new Canadian guidelines
New funding to support Canadian veterans and their families
RI-MUHC research project will examine the mental health needs of women veterans
IDIGH Program gathers at the Glen site for seventh annual research day
Researchers and trainees from the Infectious Diseases and Immunity in Global Health Program at the RI-MUHC enjoyed a stimulating day...
Defining pain in children to improve and personalize treatment
The work of RI-MUHC researchers leads to a new treatment protocol
Medical cannabis a valuable option for cancer pain relief
A new study conducted at the RI-MUHC suggests that, as a complementary therapy for cancer patients, medical cannabis could be used safely...
Researchers discover new gene variant causing inherited lung disease in Inuit
The newly discovered gene variant could contribute to high rates of Primary Ciliary Dyskinesia in Inuit populations